{
    "code": "02021761",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021761",
    "time": "2016-11-18 20:05:00",
    "許可證字號": "衛署藥輸字第021761號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/24",
    "註銷理由": "未展延而逾期者",
    "有效日期": "95\/05\/10",
    "發證日期": "86\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "02021229",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202176106",
    "中文品名": "達適康錠２０公絲",
    "英文品名": "TAMOXIFEN 20MG TABLETS",
    "適應症": "轉移性乳癌之治療",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "TAMOXIFENCITRATE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1437009100  瑪科隆股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F310005000  DOUGLAS PHARMACEUTICALS LTD.",
        "製造廠廠址": "155-161 STODDARD ROAD, MT ROSKILL, AUCKLAND",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000410",
            "成分名稱": "TAMOXIFEN CITRATE",
            "含量描述": "30.4",
            "含量": "30.4000000000",
            "單位": "MG"
        }
    ]
}